$CVV Income Statement | Understand Stock

$CVV

$4.05 +$0.14 (3.58%) Close

Financial Statements

In millions of USD; shares in millions, except per-share amounts

	FY2025 12 months to Dec 31, 2025	FY2024 12 months to Dec 31, 2024	FY2023 12 months to Dec 31, 2023	FY2022 12 months to Dec 31, 2022	FY2021 12 months to Dec 31, 2021
Consolidated total revenue
Cost of revenue
Gross profit
Operating expenses:
Research and development
Selling
General and administrative
Impairment
Gains on sales of equipment
Loss on disposition of Tantaline
Total operating expenses, net
Operating loss
Other income (expense):
Interest income
Interest expenses
Employee retention credits
Interest expense
Foreign exchange income
Gain on sale of building
Gain on debt extinguishment
Other income
Total other income, net

Total other income, net
Loss before income tax
Income tax expense
Net loss
Loss per common share:
Basic
Diluted
Weighted average number of shares:
Basic
Diluted

Comments